Dilated cardiomyopathy 1E (CMD1E) is the SCN5A-related form of familial isolated dilated cardiomyopathy, and the member of the series that most challenges the boundary between electrical and structural heart disease. SCN5A encodes Nav1.5, the pore-forming subunit of the cardiac voltage-gated sodium channel - a protein with no structural role in the sarcomere, whose other disease alleles cause the primary channelopathies Brugada syndrome, LQT3 and progressive cardiac conduction disease. In CMD1E the same gene instead produces a structural cardiomyopathy accompanied by rhythm disturbance: Olson and colleagues mapped the locus and identified the missense allele Asp1275Asn, which cosegregated with an age-dependent, variably expressed phenotype combining dilated cardiomyopathy, atrial fibrillation, impaired automaticity and conduction delay. The striking observation from that work, and the reason the entity is curated with an explicit caveat, is that similar or even identical SCN5A mutations may lead to heart failure, arrhythmia, or both - so genotype does not cleanly predict which arm dominates. ClinGen classifies the SCN5A-dilated cardiomyopathy relationship as Definitive with autosomal dominant inheritance.
Ask a research question about Dilated Cardiomyopathy 1E. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
name: Dilated Cardiomyopathy 1E
creation_date: "2026-08-23T00:00:00Z"
synonyms:
- CMD1E
- SCN5A familial isolated dilated cardiomyopathy
- dilated cardiomyopathy type 1E
- cardiomyopathy, dilated, 1E
- SCN5A dilated cardiomyopathy with conduction disease
description: >-
Dilated cardiomyopathy 1E (CMD1E) is the SCN5A-related form of familial isolated
dilated cardiomyopathy, and the member of the series that most challenges the
boundary between electrical and structural heart disease. SCN5A encodes Nav1.5,
the pore-forming subunit of the cardiac voltage-gated sodium channel - a protein
with no structural role in the sarcomere, whose other disease alleles cause the
primary channelopathies Brugada syndrome, LQT3 and progressive cardiac conduction
disease. In CMD1E the same gene instead produces a structural cardiomyopathy
accompanied by rhythm disturbance: Olson and colleagues mapped the locus and
identified the missense allele Asp1275Asn, which cosegregated with an
age-dependent, variably expressed phenotype combining dilated cardiomyopathy,
atrial fibrillation, impaired automaticity and conduction delay. The striking
observation from that work, and the reason the entity is curated with an explicit
caveat, is that similar or even identical SCN5A mutations may lead to heart
failure, arrhythmia, or both - so genotype does not cleanly predict which arm
dominates. ClinGen classifies the SCN5A-dilated cardiomyopathy relationship as
Definitive with autosomal dominant inheritance.
category: Genetic
classifications:
harrisons_chapter:
- classification_value: CARDIOVASCULAR
- classification_value: GENETICS_ENVIRONMENT_DISEASE
disease_term:
preferred_term: dilated cardiomyopathy 1E
term:
id: MONDO:0011003
label: dilated cardiomyopathy 1E
parents:
- Dilated Cardiomyopathy
- Genetic Disorder
inheritance:
- name: Autosomal dominant
description: >-
CMD1E is inherited as an autosomal dominant trait; a single SCN5A missense
allele causes disease. Expression is age-dependent and variable even within a
family, with the balance between the structural and arrhythmic arms differing
between carriers of the same variant.
inheritance_term:
preferred_term: Autosomal dominant inheritance
term:
id: HP:0000006
label: Autosomal dominant inheritance
penetrance: INCOMPLETE
evidence:
- reference: CGGV:assertion_53c90d2e-4d40-48ab-8761-b0158102c977-2025-05-30T160000.000Z
reference_title: "SCN5A / dilated cardiomyopathy (Definitive)"
supports: SUPPORT
evidence_source: OTHER
snippet: "SCN5A | HGNC:10593 | dilated cardiomyopathy | MONDO:0005021 | AD | Definitive"
explanation: >-
ClinGen's Dilated Cardiomyopathy Gene Curation Expert Panel classifies the
SCN5A-dilated cardiomyopathy relationship as Definitive with autosomal
dominant inheritance.
- reference: PMID:15671429
reference_title: "Sodium channel mutations and susceptibility to heart failure and atrial fibrillation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Mutation scans identified a missense mutation (D1275N) that cosegregated with
an age-dependent, variably expressed phenotype of DCM, atrial fibrillation,
impaired automaticity, and conduction delay.
explanation: >-
Documents cosegregation of the founding SCN5A allele with the disease and its
age-dependent, variably expressed character.
prevalence:
- population: Dilated cardiomyopathy cohorts
measure_type: UNKNOWN
prevalence_class: UNKNOWN
notes: >-
SCN5A is a definitive but numerically minor dilated cardiomyopathy gene; no
population-based rate is established for the SCN5A-specific entity.
evidence:
- reference: PMID:15671429
reference_title: "Sodium channel mutations and susceptibility to heart failure and atrial fibrillation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Heritable SCN5A defects are associated with susceptibility to early-onset DCM
and atrial fibrillation.
explanation: >-
Establishes the association of heritable SCN5A defects with early-onset
dilated cardiomyopathy in a dilated cardiomyopathy cohort study.
pathophysiology:
- name: SCN5A Missense Variant in the Cardiac Sodium Channel
biological_scale: MOLECULAR
role: trigger
conforms_to: "cardiomyopathy_maladaptive_remodeling#Primary Cardiomyocyte Insult"
description: >-
The initiating lesion in CMD1E is a heterozygous missense variant in SCN5A,
encoding the alpha subunit of the cardiac voltage-gated sodium channel Nav1.5.
The founding allele is Asp1275Asn (D1275N), identified after refined locus
mapping in a family with dilated cardiomyopathy and rhythm disturbance. Unlike
every other gene in this series, the affected protein has no structural role in
the contractile apparatus - it is an ion channel, and the same gene's other
alleles cause the primary channelopathies curated elsewhere in the knowledge
base (Brugada syndrome, progressive cardiac conduction disease).
genes:
- preferred_term: SCN5A
term:
id: hgnc:10593
label: SCN5A
cell_types:
- preferred_term: Cardiomyocyte
term:
id: CL:0000746
label: cardiac muscle cell
molecular_functions:
- preferred_term: Voltage-gated sodium channel activity
term:
id: GO:0005248
label: voltage-gated sodium channel activity
modifier: ABNORMAL
evidence:
- reference: PMID:15671429
reference_title: "Sodium channel mutations and susceptibility to heart failure and atrial fibrillation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Refined locus mapping revealed SCN5A, encoding the cardiac sodium channel, as
a candidate gene.
explanation: >-
Documents the mapping that identified SCN5A as the causal gene for this
dilated cardiomyopathy entity.
- reference: PMID:15671429
reference_title: "Sodium channel mutations and susceptibility to heart failure and atrial fibrillation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Mutation scans identified a missense mutation (D1275N) that cosegregated with
an age-dependent, variably expressed phenotype of DCM, atrial fibrillation,
impaired automaticity, and conduction delay.
explanation: >-
Names the founding SCN5A dilated cardiomyopathy allele and the composite
structural-plus-electrical phenotype it produces.
downstream:
- target: Altered Sodium Current with Conduction and Automaticity Impairment
causal_link_type: DIRECT
description: >-
The variant channel disturbs the cardiac sodium current, impairing impulse
conduction and automaticity.
- name: Altered Sodium Current with Conduction and Automaticity Impairment
biological_scale: CELLULAR
role: effector
description: >-
The mutant Nav1.5 channel disturbs the depolarizing sodium current that drives
the action potential upstroke and propagates the impulse. Clinically this
manifests as conduction delay, impaired automaticity, and a high burden of
atrial fibrillation, which in this entity accompany rather than follow the
ventricular disease. This node is the electrical arm of the phenotype and is the
point of contact with the primary SCN5A channelopathies; how the same current
disturbance also produces ventricular dilation is the entity's open mechanistic
question.
cell_types:
- preferred_term: Cardiomyocyte
term:
id: CL:0000746
label: cardiac muscle cell
biological_processes:
- preferred_term: Cardiac Conduction
term:
id: GO:0061337
label: cardiac conduction
modifier: ABNORMAL
- preferred_term: Cardiac Muscle Cell Action Potential
term:
id: GO:0086001
label: cardiac muscle cell action potential
modifier: ABNORMAL
evidence:
- reference: PMID:15671429
reference_title: "Sodium channel mutations and susceptibility to heart failure and atrial fibrillation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Mutation scans identified a missense mutation (D1275N) that cosegregated with
an age-dependent, variably expressed phenotype of DCM, atrial fibrillation,
impaired automaticity, and conduction delay.
explanation: >-
Documents the conduction delay, impaired automaticity and atrial fibrillation
that constitute the electrical arm of this node.
downstream:
- target: Ventricular Dilation and Systolic Dysfunction
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
description: >-
The route from a sodium-channel defect to structural ventricular dilation is
not established; the association is curated without asserting the intervening
steps.
- name: Ventricular Dilation and Systolic Dysfunction
biological_scale: TISSUE
role: central_effector
conforms_to: "cardiomyopathy_maladaptive_remodeling#Ventricular Remodeling"
description: >-
Carriers develop the defining structural remodeling of dilated cardiomyopathy -
left ventricular chamber enlargement with impaired systolic function - with
characteristically early onset. That an ion-channel defect produces structural
remodeling at all is the notable feature of this entity; a comparable
channel-to-structure progression is documented in SCN5A-linked progressive
cardiac conduction disease, where the sodium-channel deficit drives myocardial
fibrosis with age.
cell_types:
- preferred_term: Cardiomyocyte
term:
id: CL:0000746
label: cardiac muscle cell
- preferred_term: Cardiac Fibroblast
term:
id: CL:0002548
label: fibroblast of cardiac tissue
biological_processes:
- preferred_term: Heart Contraction
term:
id: GO:0060047
label: heart contraction
modifier: DECREASED
- preferred_term: Extracellular Matrix Organization
term:
id: GO:0030198
label: extracellular matrix organization
modifier: INCREASED
locations:
- preferred_term: Left ventricle
term:
id: UBERON:0002084
label: heart left ventricle
evidence:
- reference: PMID:15671429
reference_title: "Sodium channel mutations and susceptibility to heart failure and atrial fibrillation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Heritable SCN5A defects are associated with susceptibility to early-onset DCM
and atrial fibrillation.
explanation: >-
Establishes early-onset dilated cardiomyopathy as a consequence of heritable
SCN5A defects.
- reference: PMID:15809371
reference_title: "Mouse model of SCN5A-linked hereditary Lenègre's disease: age-related conduction slowing and myocardial fibrosis."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
a monogenic ion channel defect can progressively lead to myocardial structural
anomalies
explanation: >-
Independent demonstration that an SCN5A channel defect can drive myocardial
structural change, supporting the plausibility of the channel-to-structure
link. PARTIAL because the model is of the conduction-disease phenotype rather
than of this dilated cardiomyopathy entity.
downstream:
- target: Heart Failure and Atrial Fibrillation
causal_link_type: DIRECT
- name: Heart Failure and Atrial Fibrillation
biological_scale: ORGANISM
role: consequence
conforms_to: "cardiomyopathy_maladaptive_remodeling#Structural Cardiac Impairment and Heart Failure"
description: >-
The clinical endpoint of CMD1E has two arms that do not track together:
progressive systolic heart failure from ventricular dilation, and atrial
fibrillation with conduction disturbance from the channel defect. The founding
study's central caution is preserved here - similar or even identical SCN5A
mutations may lead to heart failure, arrhythmia, or both - so the genotype does
not predict which arm will dominate in a given carrier.
cell_types:
- preferred_term: Cardiomyocyte
term:
id: CL:0000746
label: cardiac muscle cell
biological_processes:
- preferred_term: Heart Contraction
term:
id: GO:0060047
label: heart contraction
modifier: ABNORMAL
evidence:
- reference: PMID:15671429
reference_title: "Sodium channel mutations and susceptibility to heart failure and atrial fibrillation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Similar or even identical mutations may lead to heart failure, arrhythmia, or
both.
explanation: >-
The genotype-phenotype caveat that defines this endpoint: the same SCN5A
allele can present as heart failure, as arrhythmia, or as both.
phenotypes:
- name: Dilated Cardiomyopathy
category: Cardiovascular
description: >-
Left ventricular dilation with systolic dysfunction, characteristically
early-onset, is the structural arm of CMD1E.
phenotype_term:
preferred_term: Dilated cardiomyopathy
term:
id: HP:0001644
label: Dilated cardiomyopathy
frequency: OBLIGATE
evidence:
- reference: PMID:15671429
reference_title: "Sodium channel mutations and susceptibility to heart failure and atrial fibrillation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Heritable SCN5A defects are associated with susceptibility to early-onset DCM
and atrial fibrillation.
explanation: >-
Establishes early-onset dilated cardiomyopathy as the structural phenotype of
this entity.
- name: Atrial Fibrillation
category: Cardiovascular
description: >-
Atrial fibrillation is a prominent and characteristic feature, reflecting the
channel defect rather than being merely secondary to ventricular disease.
phenotype_term:
preferred_term: Atrial fibrillation
term:
id: HP:0005110
label: Atrial fibrillation
evidence:
- reference: PMID:15671429
reference_title: "Sodium channel mutations and susceptibility to heart failure and atrial fibrillation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Heritable SCN5A defects are associated with susceptibility to early-onset DCM
and atrial fibrillation.
explanation: >-
Documents atrial fibrillation as a defining feature of heritable SCN5A
dilated cardiomyopathy.
- name: Cardiac Conduction Abnormality
category: Cardiovascular
description: >-
Conduction delay and impaired automaticity accompany the ventricular disease,
reflecting the sodium-channel lesion.
phenotype_term:
preferred_term: Cardiac conduction abnormality
term:
id: HP:0031546
label: Cardiac conduction abnormality
evidence:
- reference: PMID:15671429
reference_title: "Sodium channel mutations and susceptibility to heart failure and atrial fibrillation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Mutation scans identified a missense mutation (D1275N) that cosegregated with
an age-dependent, variably expressed phenotype of DCM, atrial fibrillation,
impaired automaticity, and conduction delay.
explanation: >-
Documents conduction delay and impaired automaticity in carriers of the
founding allele.
- name: Congestive Heart Failure
category: Cardiovascular
description: >-
Progressive systolic dysfunction produces heart failure in a subset of carriers.
phenotype_term:
preferred_term: Congestive heart failure
term:
id: HP:0001635
label: Congestive heart failure
evidence:
- reference: PMID:15671429
reference_title: "Sodium channel mutations and susceptibility to heart failure and atrial fibrillation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Similar or even identical mutations may lead to heart failure, arrhythmia, or
both.
explanation: >-
Documents heart failure as one of the two possible dominant presentations.
genetic:
- name: SCN5A
gene_term:
preferred_term: SCN5A
term:
id: hgnc:10593
label: SCN5A
relationship_type: CAUSATIVE
frequency: >-
Definitive but numerically minor cause of familial dilated cardiomyopathy;
no case fraction has been reported in a screened cohort.
evidence:
- reference: CGGV:assertion_53c90d2e-4d40-48ab-8761-b0158102c977-2025-05-30T160000.000Z
reference_title: "SCN5A / dilated cardiomyopathy (Definitive)"
supports: SUPPORT
evidence_source: OTHER
snippet: >-
SCN5A | HGNC:10593 | dilated cardiomyopathy | MONDO:0005021 | AD |
Definitive
explanation: >-
ClinGen's Gene Curation Expert Panel classifies this gene-disease
relationship as Definitive, which is the authority for curating the gene
as CAUSATIVE rather than a candidate.
- reference: PMID:15671429
reference_title: "Sodium channel mutations and susceptibility to heart failure and atrial fibrillation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Mutation scans identified a missense mutation (D1275N) that cosegregated
with an age-dependent, variably expressed phenotype of DCM, atrial
fibrillation, impaired automaticity, and conduction delay.
explanation: >-
Cosegregation of the D1275N allele with the composite
dilated-cardiomyopathy, atrial-fibrillation and conduction phenotype is
the founding gene-disease observation for this entry.
- reference: PMID:15671429
reference_title: "Sodium channel mutations and susceptibility to heart failure and atrial fibrillation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Heritable SCN5A defects are associated with susceptibility to
early-onset DCM and atrial fibrillation.
explanation: >-
States the gene-disease relationship in susceptibility terms, which
together with the incomplete penetrance recorded under inheritance is
why the allele is curated as causative with variable expression rather
than fully penetrant.
treatments:
- name: Heart Failure Pharmacotherapy
description: >-
Standard guideline-directed heart-failure therapy for the structural arm.
therapeutic_modality: SMALL_MOLECULE
treatment_term:
preferred_term: Pharmacotherapy
term:
id: NCIT:C15986
label: Pharmacotherapy
- name: Rhythm and Conduction Management
description: >-
Management of atrial fibrillation and conduction disease, including
anticoagulation where indicated and pacing for symptomatic bradyarrhythmia,
addresses the electrical arm of the phenotype.
therapeutic_modality: DEVICE
treatment_term:
preferred_term: pacemaker placement
term:
id: NCIT:C80434
label: Pacemaker Placement
references:
- reference: PMID:20301486
title: Dilated Cardiomyopathy Overview.
tags:
- GeneReviews
notes: >-
CMD1E is the SCN5A member of the numbered dilated cardiomyopathy series and
carries ClinGen Definitive gene-disease validity. It conforms to the shared
cardiomyopathy_maladaptive_remodeling module.
It is the mechanistic outlier of the series and is curated as such. Every other
member's causal protein has a structural, regulatory or maintenance role in the
cardiomyocyte; SCN5A encodes an ion channel, and its other alleles cause the
primary channelopathies curated elsewhere here - Brugada syndrome and Progressive
Cardiac Conduction Disease. The entity therefore sits at the boundary between
electrical and structural heart disease.
Two caveats preserved rather than smoothed over. (1) The link from the channel
defect to ventricular dilation is curated as
INDIRECT_UNKNOWN_INTERMEDIATES: the association is well established but the
intervening mechanism is not, and the supporting evidence that a monogenic channel
defect can drive structural change comes from a model of the *conduction-disease*
phenotype, so it is marked PARTIAL. (2) The founding study's own caution is
curated on the endpoint node - similar or even identical SCN5A mutations may lead
to heart failure, arrhythmia, or both - so this entry does not claim that genotype
predicts which arm dominates.
GeneReviews scope. The GeneReviews resource applicable to this entry is the
disease-level "Dilated Cardiomyopathy Overview" (PMID:20301486), tagged
accordingly in `references`. Its indexed PubMed record is content_type
abstract_only and carries only the chapter's purpose statement, not the
Clinical Characteristics, Management, or Genetic Counseling sections, so
section-by-section GeneReviews mining is not possible from the cache and no
snippet is quoted from it. The clinical-characteristics baseline for this
entry is therefore built from the primary SCN5A cohort and pedigree literature
cited throughout, principally PMID:15671429.